遗传性弥漫性胃癌:更新版临床实践指南
国际胃癌连锁联盟(IGCLC)发布遗传性弥漫性胃癌(HDGC)更新版临床实践指南。指南认识到家族间胃癌风险差异、内镜与组织学监测能力提升及年轻患者全胃切除远期后遗症管理经验增加,放宽了基因检测标准(主要通过减少年龄限制),预防性全胃切除仍是CDH1致病变异携带者推荐的胃癌风险管理选择,但专家中心内镜监测可安全提供给希望推迟手术或风险未明确者。
要点
- HDGC为常染色体显性遗传综合征,主要由CDH1胚系失活突变引起,少数家族有CTNNA1致病变异。
- 基因检测标准已放宽,主要通过减少年龄限制,以平衡检测可及性、成本与接受度及致病变异携带者识别增加。
- 预防性全胃切除仍是CDH1致病变异携带者推荐的胃癌风险管理选择。
核心结论
- 预防性全胃切除仍是CDH1致病变异携带者推荐的胃癌风险管理选择。
- 专家中心内镜监测可安全提供给希望推迟手术或胃癌风险未明确者。
研究设计与样本
- 国际胃癌连锁联盟(IGCLC)发布的Policy Review类更新版临床实践指南。
主要发现
- 认识到HDGC家族间胃癌风险存在变异性。
- 内镜与组织学监测能力在HDGC中不断增强。
- 年轻患者全胃切除远期后遗症管理经验增加。
关键数值与推荐
- HDGC基因检测标准已放宽,主要通过减少年龄限制。
- 预防性全胃切除仍是CDH1致病变异携带者推荐的胃癌风险管理选择。
- 专家中心内镜监测可安全提供给希望推迟手术或胃癌风险未明确者。
临床怎么用
- 对符合放宽后基因检测标准者进行CDH1等基因检测。
- CDH1致病变异携带者推荐预防性全胃切除作为胃癌风险管理选择。
- 希望推迟手术或胃癌风险未明确者可在专家中心接受内镜监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour suppressor gene CDH1, although pathogenic variants in CTNNA1 occur in a minority of families with HDGC. In this Policy Review, we present updated clinical practice guidelines for HDGC from the International Gastric Cancer Linkage Consortium (IGCLC), which recognise the emerging evidence of variability in gastric cancer risk between families with HDGC, the growing capability of endoscopic and histological surveillance in HDGC, and increased experience of managing long-term sequelae of total gastrectomy in young patients. To redress the balance between the accessibility, cost, and acceptance of genetic testing and the increased identification of pathogenic variant carriers, the HDGC genetic testing criteria have been relaxed, mainly through less restrictive age limits. Prophylactic total gastrectomy remains the recommended option for gastric cancer risk management in pathogenic CDH1 variant carriers. However, there is increasing confidence from the IGCLC that endoscopic surveillance in expert centres can be safely offered to patients who wish to postpone surgery, or to those whose risk of developing gastric cancer is not well defined.
引用
- Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020. PMID: 32758476. doi:10.1016/S1470-2045(20)30219-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。